| 臺大學術典藏 |
2021-07-02T03:42:55Z |
Sex differences in pediatric systemic lupus erythematosus: a retrospective analysis of 135 cases.
|
Lo J.T.; Tsai M.J.; Wang L.H.; Huang M.T.; Yang Y.H.; Lin Y.T.; Liu J.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:54Z |
Autoimmune manifestations in patients with primary immunodeficiency
|
Wang L.-H.; Tsai M.-J.; Huang M.-T.; Lin S.-C.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:53Z |
Clinical observations of erythema multiforme in children
|
Yang Y.-H.; Tsai M.-J.; Tsau Y.-K.; Wang L.-H.; Lin Y.-T.; Liu J.C.J.; Lo J.-T.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:53Z |
Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): Optimization and definition of cellular immune responses
|
BOR-LUEN CHIANG; Sheih Y.H.; Wang L.H.; Liao C.K.; Gill H.S. |
| 臺大學術典藏 |
2021-07-02T03:42:51Z |
Lichen sclerosus et atrophicus, bullous morphea, and systemic lupus erythematosus: A case report
|
Wu K.-H.; Dai Y.-S.; Tsai M.-J.; Lin S.-C.; Wang L.-H.; Huang M.-T.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:50Z |
Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis - A case report
|
Wang L.-H.; Tsai M.-J.; Tsai W.-Y.; Lee J.-S.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:49Z |
Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis
|
Lin Y.-T.; Tsai M.-J.; Wang L.-H.; Huang M.-T.; Yang Y.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:48Z |
Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001
|
Sheih Y.-H.; BOR-LUEN CHIANG; Wang L.-H.; Liao C.-K.; Gill H.S. |
| 臺大學術典藏 |
2021-07-02T03:42:47Z |
β2-agonist exerts differential effects on the development of cord blood T cells but not on peripheral blood T cells
|
Huang M.-T.; Yang Y.-H.; Lin Y.-T.; Lu M.-Y.; Wang L.-H.; Tsai M.-J.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:42:39Z |
The changes of mite-specific immunoglobulin A and transforming growth factor-β1 during immunotherapy of children with dust mite allergy
|
Wang L.-H.; Yang Y.-H.; Tsai M.-J.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-05-26T03:35:33Z |
Dissemination of two methicillin-resistant Staphylococcus aureus clones exhibiting negative staphylase reactions in intensive care units
|
Hsueh P.-R.; Teng L.-J.; Yang P.-C.; Pan H.-J.; Chen Y.-C.; Wang L.-H.; Ho S.-W.; KWEN-TAY LUH |
| 臺大學術典藏 |
2021-05-26T03:35:28Z |
Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and multiple clones
|
Hsueh P.-R.; Teng L.-J.; Pan H.-J.; Chen Y.-C.; Wang L.-H.; Chang S.-C.; Ho S.-W.; KWEN-TAY LUH |
| 臺大學術典藏 |
2021-05-18T07:11:44Z |
Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan
|
Chen C.-J.;Hsu L.-I.;Wang C.-H.;Wei-Liang Shih;Hsu Y.-H.;Tseng M.-P.;Lin Y.-C.;Chou W.-L.;Chen C.-Y.;Lee C.-Y.;Wang L.-H.;Cheng Y.-C.;Chen C.-L.;Chen S.-Y.;Wang Y.-H.;Hsueh Y.-M.;Chiou H.-Y.;Wu M.-M.; Chen C.-J.; Hsu L.-I.; Wang C.-H.; WEI-LIANG SHIH; Hsu Y.-H.; Tseng M.-P.; Lin Y.-C.; Chou W.-L.; Chen C.-Y.; Lee C.-Y.; Wang L.-H.; Cheng Y.-C.; Chen C.-L.; Chen S.-Y.; Wang Y.-H.; Hsueh Y.-M.; Chiou H.-Y.; Wu M.-M. |
| 臺大學術典藏 |
2021-05-06T01:52:57Z |
Infection Control and SARS Transmission among Healthcare Workers, Taiwan
|
YEE-CHUN CHEN; Chen P.-J.; Chang S.-C.; Kao C.-L.; Wang S.-H.; Wang L.-H.; Yang P.-C.; Chen D.-S.; Lee Y.-T.; Teng C.-M.; Ho H.-N.; Chang M.-F.; Wang J.-T.; Kao C.-L.; Wang W.-K.; Hsiao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-06T01:52:53Z |
Control of vancomycin-resistant enterococci in a hospital: A five-year experience in a Taiwanese teaching hospital
|
Wang J.-T.; YEE-CHUN CHEN; Chang S.-C.; Chen M.-L.; Pan H.-J.; Chang Y.-Y.; Sun C.-C.; Wang L.-H.; Wang S.-H.; Lin H.-C.; Chien S.-F.; Tseng M.-S. |
| 臺大學術典藏 |
2021-03-11T08:34:31Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:31Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:30Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
Jen-Chang Ko;Wang L.-H.;Jhan J.-Y.;Ciou S.-C.;Hong J.-H.;Lin S.-T.;Lin Y.-W.; JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:30Z |
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:43Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:43Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:42Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:42Z |
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
